Početna › Miastenija gravis › Illinois
Kliničke studije za Miastenija gravis u državi Illinois
12 studija za Miastenija gravis traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10105, O'Fallon
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- HSHS St. Elizabeth's Hospital, O'Fallon
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07217587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- HSHS Medical Group - St. Elizabeth's Hospital, O'Fallon
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT07501702RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 13. kol 2026. · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Chicago
- Aurinia Investigational Site, O'Fallon
U tijeku regrutacijaFaza 1/2
Od 18 do 85 godina · Oba spola · Ažurirano 3. kol 2026. · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Hospital Sisters Health System Medical, O'Fallon
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. lip 2026. · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Chicago
- Research Site, Schaumburg
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 9. tra 2026. · NCT07221838Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago
U tijeku regrutacijaFaza 2/3
Od 2 do 18 godina · Oba spola · Ažurirano 18. velj 2026. · NCT04833894A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Prairie Education and Research Cooperative and HSHS Medical Group, O'Fallon
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2026. · NCT06298565Vitaccess Real MG Registry
- HSHS St. Elizabeth's Hospital, O'Fallon
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2025. · NCT06064461Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
- ZS Associates, Evanston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 10. ožu 2025. · NCT06866483Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.